Skip to content
healthcare.dev

GUNA-COUGH

NDC 17089-453, ALTHAEA OFFICINALIS LEAF - ANTIMONY POTASSIUM TARTRATE - BRYONIA ALBA ROOT - CETRARIA ISLANDICA SUBSP. ISLANDICA - COCHINEAL - COPPER - DROSERA ROTUNDIFOLIA - ECHINACEA ANGUSTIFOLIA - GARDEN THYME - LOBARIA PULMONARIA - PLANTAGO MAJOR -, solution/ drops, from Guna spa.

Product NDC
17089-453
Status
Listed
Labeler
Guna spa
Dosage form
SOLUTION/ DROPS
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17089-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALTHAEA OFFICINALIS LEAF1 [hp_X]/150mL
  • ANTIMONY POTASSIUM TARTRATE8 [hp_X]/150mL
  • BRYONIA ALBA ROOT6 [hp_X]/150mL
  • CETRARIA ISLANDICA SUBSP. ISLANDICA4 [hp_X]/150mL
  • COCHINEAL6 [hp_X]/150mL
  • COPPER8 [hp_X]/150mL
  • DROSERA ROTUNDIFOLIA1 [hp_X]/150mL
  • ECHINACEA ANGUSTIFOLIA1 [hp_X]/150mL
  • PLANTAGO MAJOR1 [hp_X]/150mL
  • LOBARIA PULMONARIA4 [hp_X]/150mL
  • THYME1 [hp_X]/150mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Dietary Proteins [CS]; Food Additives [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Inhibit Ovum Fertilization [PE]; Non-Standardized Food Allergenic Extract [EPC]

Package NDCNDC-11Package
17089-453-24170890453241 BOTTLE in 1 BOX (17089-453-24) / 150 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 17089-453 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17089-453 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17089-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.